Expert consensus
Primary re-excision (PRE) in order to achieve complete resection (R0) in patients with macroscopic or microscopic tumor residuals after biopsy or resection, before any adjuvant therapy (IRS Group II or III), is usually not indicated in patients with vaginal RMS.